No recent analyst price targets found for SHIEF.
Latest News for SHIEF
Shield shares jump after FDA extends Accrufer exclusivity
Broker Cavendish says additional US protection strengthens long-term outlook and reiterates buy rating. Shares in Shield Therapeutics PLC (AIM:STX, OTCQB:SHIEF) jumped as much 11% earlier in the session after the company said US regulators had granted an additional three years of data exclusivity for its oral iron therapy Accrufer.
Shield Therapeutics plc (SHIEF) Q4 2025 Sales/Trading Call Transcript
Shield Therapeutics plc (SHIEF) Q4 2025 Sales/Trading Call Transcript
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for SHIEF.
Senate Trading
No Senate trades found for SHIEF.
U.S. House Trading
No House trades found for SHIEF.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.